Clin2
NCT07744386Likely a fitNot yet recruiting

How a new medicine affects blood thinner and cholesterol drug

Healthy Male Volunteers

Treatments studied

This study tests how a new investigational medicine affects the way your body handles two common drugs: a blood thinner (dabigatran) and a cholesterol-lowering medicine (rosuvastatin). It helps researchers understand if the new medicine is safe to use together with these drugs.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are male and between 18 and 55 years old.
  • Your weight is within a healthy range for your height (body mass index between 18 and 30).
  • You are a non-smoker or stopped smoking long ago (less than 5 pack-years).
  • You are generally healthy, with no major medical conditions and no bleeding disorders.
  • You are not taking any medicines, supplements, or herbal products that could interfere.
  • You have not joined another clinical trial in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07629999Recruiting· Phase 1
Safety study of experimental drug BMS-986533 in healthy people

This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.

Lincoln, Nebraska
NCT07785830Not yet recruiting· Phase 1
How a new drug affects a common cholesterol medicine

This study checks if a new investigational drug (MK-4646) changes how the body handles rosuvastatin, a common cholesterol-lowering medicine. It is for healthy people to see if the new drug is safe to take together.

South Miami, Florida
NCT07820891Recruiting· Phase 1
Healthy volunteer study for BGB-43395 drug interactions

This study tests whether a new medicine, BGB-43395, interacts with other drugs in healthy people. It helps doctors understand how the drug is processed, which is important for future patients.

Dallas, Texas
NCT07240636Recruiting· Phase 1
How food affects a new medicine in healthy volunteers

This trial studies how food changes the way your body processes a new medicine called VV119. It helps make sure the drug works safely and effectively. Healthy adults are needed to participate.

Hefei, Anhui
NCT07421375Not yet recruiting· Phase 1
Study of a new medicine for healthy volunteers

This trial tests a new medicine in healthy people to see how it is absorbed and broken down by the body, and to make sure it is safe. If you join, you will take the medicine under fasting conditions and have regular blood tests.

NCT07162441Recruiting· Phase 1
Drug interaction study in healthy volunteers

This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.

Seoul, Gwanak-gu

Hear when a new Healthy Male Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.